Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units

Langenbeck's Archives of Surgery

Volumn 386, Issue 1, 2001, Pages 47-52

  Dotzenrath, Cornelia ^a,b   Goretzki, Peter E ^a,b   Cupisti, Kenko ^a,b   Simon, Dietmar ^a,b   Witte, Jürgen ^a,b   Yang, Qin ^a,b   Ohmann, C ^a,b   Roher, Hans Dietrich ^a,b  

^a St Antonius Kliniken   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Diagnostics; Medullary thyroid carcinoma; Questionnaire; Standard procedure; Surgery

Indexed keywords

ARTICLE; CANCER CENTER; CANCER LOCALIZATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; ECHOGRAPHY; FAMILIAL CANCER; HUMAN; IMAGE ANALYSIS; LYMPHADENECTOMY; MEDICAL PRACTICE; MEDULLARY CARCINOMA; NECK DISSECTION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT CANCER; REOPERATION; SCINTIGRAPHY; SURGICAL TECHNIQUE; THYROID CANCER; THYROIDECTOMY; TREATMENT PLANNING;

CARCINOMA, MEDULLARY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SURGERY DEPARTMENT, HOSPITAL; THYROID NEOPLASMS;

EID: 0035119335     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230000186     Document Type: Article

References (35)

1. Deutsche Gesellschaft für Chirurgie (1996) Leitlinien der Chirurgie maligner Schilddrüsentumoren. In: Grundlagen der Chirurgie. G 70. Demeter Verlag, Baiingen
2. Moiey JF, DeBenedetti MK (1999) Patterns of nodal métastases in palpable medullary thyroid cancer. Ann Surg 229:880-888
3. Bergholm U, Adami HO, Bergström R, Johansson H (1989) Clinical characteristics in sporadic and familial medullary thyroid cancer. Cancer 63:1196-1204
4. Beressi N, Campos JM, Beressi JP, Franc B. Niccoli-Sire P, Conte-Delvox B, Murat A. Caron P Baldet L, Kraimps JL, Cohen R, Bigorgne JC, Chabre O, Lecomte P, Modigliani E (1998) Sporadic medullary thyroid microcarcinoma of the thyroid: a retrospective analysis of eighty cases. Thyroid 8:1039-1044
5. Dralle H, Scheumann GFW, Proye C, Bacour F ( 1995) The value of lymphnode dissection in hereditary medullary thyroid carcinoma: a retrospective European multicentre study. J Intern Med 238:357
6. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22:562-568
7. Wagner HE, Ruchti C, Studer M, Haldemann AR, Kinser J, Bürgi U (1996) Langzeitverlauf des medullären Schilddrüsenkarzinomes. Swiss Surg 2:181-186
8. Kallinowski F, Buhr HJ, Meybier H, Eberhardi M, Herfarth C (1993) Medullary carcinoma of the thyroid - therapeutic strategy derived from fifteen years of experience. Surgery 114:491-496
9. Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid cancer. Cancer 77:1556-1565
10. Moley JF, Dilley WG, DeBenedetti MK (1997) Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 225:734743
11. Gimm O, Dralle H (1997) Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage- oriented approach justified? Surgery 122:1124-1131
12. Cupisti K, Simon D. Wolf A, Gerharz CD, Goretzki P, Dotzenrath C, Witte, J Roher HD (2000) Surgical strategy in small sporadic C-Cell carcinoma. Langenbecks Arch Surg 385:526530
13. Tisell LE, Hansson G, Jansson S. Salander H (1986) Reoperation in the treatment of medullary thyroid carcinoma. Surgery 99:60-66
14. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM (1990) Long term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395-401
15. Heshamati HM, Gharib H, van Heerden JA (1997) Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. Am JMed 103:60-69
16. Frank K, Raue F, Lorenz D, Herfarth C, Ziegler R ( 1987) Importance of ultrasound examination for the follow-up of medullary thyroid carcinoma: comparison with other localization methods. Henry Ford Hosp Med J 35:122-123
17. Auffermann W, Clark OH, Thurnher S. Galante M, Higgins CB (1988) Recurrent thyroid carcinoma: characteristics on MR images. Radiology 168:753-757
18. Cupisti K, Simon D, Dotzenrath C, Goretzki PE, Roher HD (1997) Ergebnisse des selektiven venösen Etagenkatheters (SVK) beim okkulten C-Zell-Karzinom der Schilddrüse. Langenbecks Arch Chir 382:295-301
19. Mrad MDB, Gardet P, Röche A, Rougier P, Calmettes C, Motte P, Parmentier C ( 1989) Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma. Cancer 63:133-138
20. Frank-Raue K, Raue F, Buhr HJ, Baldauf G, Lorenz D, Ziegler R ( 1992) Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 2:113-117
21. Abdelmoumene N, Schlumberger M, Gardet P, Roche A, Travagli JP, Francese C, Parmentier C (1994) Selective venous sampling catheterization for localisation of persisting medullary thyroid carcinoma. Br J Cancer 69:1141-1144
22. Buhr HJ, Kallinowski F, Raue F, Frank-Raue K, Herfarth C (1993) Microsurgical neck dissection for occult metastizing medullary thyroid carcinoma. Cancer 72:3685-3693
23. Tung WS, Vesely TM, Moley JF (1995) Laparoscopic detection of hepatic métastases in patients with residual or recurrent medullary thyroid cancer. Surgery 118:1024-1030
24. Kwekkeboom DJ, Lamberts SWJ, Habbema JDF, Krenning EP (1996) Cost-effectiveness analysis of somatostatin receptor scintigraphy. J Nucl Med 37:886-892
25. Kwekkeboom DJ, Reubi JC, Lamberts SWJ, Bruining HA, Mulder AH. Oei HY, Krenning EP ( 1993) In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Endocrinol Metab 76:1413-1417
26. Learoyd DL, Roach Pi. Briggs GM, Delbridge LW, Wilmhurst EG, Robinson BG (1997) Technetium-99mSestamibi Scanning in recurrent medullary thyroid carcinoma. J Nucl Med 38:227-230
27. Liewendahl K, Valimaki M, Taavitsainen M (1993) Localization of hepatic métastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with MTC. Eur J Nucl Med 20:551-554
28. Hoefnagel CA, Delprat CC, Zanin D, van der School JB (1988) New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 13:159-165
29. Simon GH, Nitsche EU, Laubenberger JJ, Einert A, Moser E (1996) PET imaging of recurrent medullary thyroid cancer. Nuklearmedizin 35:102-104
30. Moley JF, Wells SA, Dilley WG, Tisell LE (1993) Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090-1096
31. Norton JA, Doppman JL, Brennan ME ( 1980) Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 87:616-622
32. Dralle H, Grimm O (1996) Lymphadenektomie beim Schilddrüsenkarzinom. Chirurg 67:788-806
33. Chen H, Roberts JR. Ball DW. Eisele DW, Baylin BB, Udelsman R, Bulkley GB (1998) Effective long-term palliation of symptomatic incurable metastatic medullary thyroid cancer by operative resection. Ann Surg 227:887-895
34. Ellenhorn JD, Shah JR Brennan MF (1993) Impact of therapeutic regional lymph node dissection for medullary thyroid carcinoma of the thyroid gland. Surgery 114:1078-1081
35. Juweid ME, Hajjar G, Swayne LC, Sharkey RM, Suleiman S, Herskovic T, Pereira M, Rubin AD, Goldenberg DM ( 1999) Phase I/1I Trial of 1311-MN14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic MTC. Cancer 85:1828-1842